DE
Brendan Frey’s MaRS company. Uses foundation models on the genome to find RNA therapeutics — one of the few Toronto biotechs VCs outside Canada can name.
Open desks
- Computational BiologistApply
Discovery · Full-time
Health
Deep Genomics
RNA medicines discovered by machine.